NYSE - Nasdaq Real Time Price USD

XPeng Inc. (XPEV)

19.23
-0.51
(-2.61%)
As of 2:34:53 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 16.11B
Earnings -1.39B

Q1'24

Q2'24

Q3'24

Q4'24

0
5B
10B
15B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

12.03 Low
24.83 Average
19.23 Current
32.03 High

Earnings Estimate

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3385
Avg. Estimate -1.51-1.39-2.821.76
Low Estimate -2.03-2.19-7.890.73
High Estimate -1-0.48-1.182.57
Year Ago EPS -1.49-1.29-5.87-2.82

Revenue Estimate

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 553137
Avg. Estimate 15.8B16.88B80.47B109.23B
Low Estimate 15.1B14.83B60.7B78.66B
High Estimate 16.53B17.81B94.58B147.63B
Year Ago Sales 6.55B8.11B40.87B80.47B
Sales Growth (year/est) 141.22%108.06%96.92%35.73%

Earnings History

Currency in CNY 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -1.77-1.32-1.69-1.45
EPS Actual -1.49-1.29-1.62-1.47
Difference 0.280.030.07-0.02
Surprise % 15.95%1.98%4.33%-1.57%

EPS Trend

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -1.51-1.39-2.821.76
7 Days Ago -1.15-1.37-2.821.34
30 Days Ago -1.59-1.69-2.790.81
60 Days Ago -1.59-1.69-3.08-0.39
90 Days Ago -1.59-1.69-3.06-0.43

EPS Revisions

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 12----
Up Last 30 Days 1141
Down Last 7 Days 21----
Down Last 30 Days 112--

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
XPEV -1.48%-7.47%51.94%162.41%
S&P 500 12.50%3.24%7.95%13.84%

Upgrades & Downgrades

Maintains Barclays: Underweight to Underweight 3/20/2025
Maintains JP Morgan: Overweight to Overweight 3/19/2025
Maintains B of A Securities: Buy to Buy 3/19/2025
Upgrade Citigroup: Neutral to Buy 3/10/2025
Upgrade UBS: Sell to Neutral 2/24/2025
Downgrade Macquarie: Outperform to Neutral 2/7/2025

Related Tickers